Can 68Ga-PSMA-11 PET/CT predict pathological upgrading of prostate cancer from MRI-targeted biopsy to radical prostatectomy?

被引：0
|
作者：
Haoli Yin
Mengxia Chen
Xuefeng Qiu
Li Qiu
Jie Gao
Danyan Li
Yao Fu
Haifeng Huang
Suhan Guo
Qing Zhang
Shuyue Ai
Feng Wang
Hongqian Guo
机构：
[1] Medical School of Nanjing University,Department of Urology, Affiliated Drum Tower Hospital
[2] Nanjing University,Institute of Urology
[3] The Ohio State University,Department of Math, College of Art and Science
[4] Medical School of Nanjing University,Department of Radiology, Affiliated Drum Tower Hospital
[5] Medical School of Nanjing University,Department of Pathology, Affiliated Drum Tower Hospital
[6] Nanjing University,School of Artificial Intelligence
[7] Nanjing Medical University,Department of Nuclear Medicine, Nanjing First Hospital
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
Prostate cancer; Targeted biopsy; MRI; PSMA PET/CT; Upgrading;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3693 / 3701
页数：8
相关论文
共 50 条
  • [1] Can 68Ga-PSMA-11 PET/CT predict pathological upgrading of prostate cancer from MRI-targeted biopsy to radical prostatectomy?
    Yin, H.
    Chen, M.
    Qiu, X.
    Qiu, X.
    Guo, H.
    EUROPEAN UROLOGY, 2021, 79 : S1278 - S1278
  • [2] Can 68Ga-PSMA-11 PET/CT predict pathological upgrading of prostate cancer from MRI-targeted biopsy to radical prostatectomy?
    Yin, Haoli
    Chen, Mengxia
    Qiu, Xuefeng
    Qiu, Li
    Gao, Jie
    Li, Danyan
    Fu, Yao
    Huang, Haifeng
    Guo, Suhan
    Zhang, Qing
    Ai, Shuyue
    Wang, Feng
    Guo, Hongqian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (11) : 3693 - 3701
  • [3] Deep learning based on 68Ga-PSMA-11 PET/CT for predicting pathological upgrading in patients with prostate cancer
    Zang, Shiming
    Jiang, Cuiping
    Zhang, Lele
    Fu, Jingjing
    Meng, Qingle
    Wu, Wenyu
    Shao, Guoqiang
    Sun, Hongbin
    Jia, Ruipeng
    Wang, Feng
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [4] Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy
    Benedikt Kranzbühler
    Hannes Nagel
    Anton S. Becker
    Julian Müller
    Martin Huellner
    Paul Stolzmann
    Urs Muehlematter
    Matthias Guckenberger
    Philipp A. Kaufmann
    Daniel Eberli
    Irene A. Burger
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 20 - 30
  • [5] Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy
    Kranzbuhler, Benedikt
    Nagel, Hannes
    Becker, Anton S.
    Mueller, Julian
    Huellner, Martin
    Stolzmann, Paul
    Muehlematter, Urs
    Guckenberger, Matthias
    Kaufmann, Philipp A.
    Eberli, Daniel
    Burger, Irene A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (01) : 20 - 30
  • [6] Potential value of 68Ga-PSMA-11 PET to predict biochemical recurrence in primary prostate cancer after radical prostatectomy
    Wang, H.
    Amiel, T.
    Langbein, T.
    Rauscher, I.
    Horn, T.
    Heck, M.
    Maurer, T.
    Weber, W.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S265 - S266
  • [7] The impact of 68Ga-PSMA-11 PET/MRI studies in patients with biochemical relapse of prostate cancer after radical prostatectomy
    Freitag, Martin
    Radtke, Jan
    Hadaschik, Boris
    Kopka, Klaus
    Sachpekidis, Christos
    Frederik, Giesel
    Haberkorn, Uwe
    Schlemmer, Heinz-Peter
    Dimitrakopoulou-Strauss, Antonia
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [8] Can patient selection based on 68Ga-PSMA-11 PET improve the outcome of radical prostatectomy in prostate cancer patients?
    Burger, I. A.
    Ferraro, D. A.
    Muehlematter, U. J.
    Schuler, H. I. Garcia
    Eberli, D.
    Hermanns, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S448 - S449
  • [9] Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
    Kesler, Mikhail
    Cohen, Dan
    Levine, Charles
    Sarid, David
    Keizman, Daniel
    Yossepowitch, Ofer
    Even-Sapir, Einat
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (07) : 1030 - 1035
  • [10] 68Ga-PSMA-11 PET/CT versus 68Ga-PSMA-11 PET/MRI for the detection of biochemically recurrent prostate cancer: a systematic review and meta-analysis
    Huang, Ruizhe
    Li, Yizhen
    Wu, Haowen
    Liu, Boyi
    Zhang, Xuanjun
    Zhang, Zhongxi
    FRONTIERS IN ONCOLOGY, 2023, 13
12345